Integrum AB (publ)

Stockholm Stock Exchange INTEG-B.ST

Integrum AB (publ) Gross Profit Margin for the year ending April 30, 2024: 87.65%

Integrum AB (publ) Gross Profit Margin is 87.65% for the year ending April 30, 2024, a 7.00% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.

Integrum AB (publ) Gross Profit Margin for the year ending April 30, 2023 was 81.92%, a -1.95% change year over year.
Integrum AB (publ) Gross Profit Margin for the year ending April 30, 2022 was 83.55%, a 3.20% change year over year.
Integrum AB (publ) Gross Profit Margin for the year ending April 30, 2021 was 80.96%, a 1.35% change year over year.
Integrum AB (publ) Gross Profit Margin for the year ending April 30, 2020 was 79.88%, a 2.18% change year over year.

Key data

Date	Gross Profit Margin	Operating Income Margin	EBT Margin	Net Income Margin

Stockholm Stock Exchange: INTEG-B.ST

Integrum AB (publ)

CEO	Mr. Scott D. Flora
IPO Date	May 15, 2017
Location	Sweden
Headquarters	Krokslätts Fabriker 50
Employees	36
Sector	Health Care
Industries Pharmaceuticals Biotechnology

Description

Integrum AB (publ) researches, develops, and sells various systems for bone-anchored prostheses. The company provides Osseointegrated Prostheses for the Rehabilitation of Amputees (OPRA) implant systems, a bone-anchored prostheses system based on osseointegration, where the prostheses are directly attached to the bone, avoiding the use of socket. The OPRA implant system offers protection to the patient by avoiding bone fractures from accidental loads. The company also provides Neuromotus, a technology that is used for therapy to reduce phantom limb pain after an amputation. It sells its implant systems to hospitals, clinics, and orthopedists worldwide. The company was founded in 1962 and is headquartered in Mölndal, Sweden.

Key trends

Past 5 years